Generic Name and Formulations:
Acrivastine 8mg, pseudoephedrine HCl 60mg; caps.
Indications for SEMPREX-D:
Seasonal allergic rhinitis symptoms.
1 cap every 4–6hrs; max 4 caps/day.
Severe hypertension or coronary artery disease. During or within 14 days of MAOIs.
Hypertension. Diabetes. Ischemic heart disease. Increased intraocular pressure. Hyperthyroidism. Prostatic hypertrophy. Peptic ulcer. GI obstruction. Renal impairment (CrCl ≤48mL/minute): not recommended. Elderly. Pregnancy (Cat.B). Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Avoid concomitant CNS depressants, OTC antihistamines and decongestants, alcohol. Potentiated by beta agonists. Antagonizes antihypertensives.
Somnolence, dry mouth, nervousness, insomnia, ephedrine-like reactions (tachycardia, palpitations, headache, dizziness, nausea).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children